期刊文献+

应激性高血糖与急性心肌梗死的机制研究 被引量:3

Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction
下载PDF
导出
摘要 应激性高血糖属于机体自我保护机制,在应激状态下可引起非特异性适应性的血糖变化,常见于急性心肌梗死等疾病中。近年来多项研究发现,应激性高血糖可促使急性心肌梗死病情的恶化,对其病情严重程度及患者预后结局均具有不良影响,其作用机制可涉及氧化应激反应、凝血及抗凝系统失衡、血管内皮功能障碍及无复流等。基于此,本文结合急性心肌梗死患者应激性高血糖的发生机制及损伤原理,对其研究进展作一综述,以供临床参考。 Stress hyperglycemia belongs to the body's self-protection mechanism,which can cause non-specific adaptive changes in blood glucose under stress,and is common in acute myocardial infarction and other diseases.In recent years,a number of studies have found that stress hyperglycemia can promote the deterioration of acute myocardial infarction,which has adverse effects on the severity of the disease and the prognosis of patients.Its mechanism can be related to oxidative stress response,imbalance of coagulation and anticoagulation system,vascular endothelial dysfunction and no-reflow.Based on this,this paper reviews the research progress of stress hyperglycemia in patients with acute myocardial infarction in combination with the mechanism and damage principle of stress hyperglycemia,so as to provide clinical reference.
作者 何丽 HE Li(Department of Physical Examination,Tianjin Occupational Diseases Precaution and Therapeutic Hospital,Tianjin 300011,China)
出处 《医学信息》 2022年第10期74-77,共4页 Journal of Medical Information
关键词 应激性高血糖 急性心肌梗死 氧化应激 胰岛素抵抗 无复流 Stress hyperglycemia Acute myocardial infarction Oxidative stress Insulin resistance No reflow
  • 相关文献

参考文献24

二级参考文献166

  • 1王占辉,刘彦君.2012加拿大成人2型糖尿病筛查指南解读[J].中国医学前沿杂志(电子版),2013,5(5):47-52. 被引量:1
  • 2钟世勤,钟惠娟,侯维宁.急性心肌梗死后应激性高血糖诊断标准的探讨[J].中国心血管病研究,2005,3(9):694-695. 被引量:16
  • 3刘宏伟,王加玑.高血压病和冠心病胰岛素抵抗与血管紧张素Ⅱ及内皮素的关系[J].中华内科杂志,1996,35(8):520-523. 被引量:14
  • 4Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment:insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 1985,28:412- 419.
  • 5Gibson CM, Cannon CP, Murphy SA,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation ,2000,101 : 125-130.
  • 6Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ' no reflow' phenomenon. A predictor of complications and left ventriccular remodeling in reperfused anterior wall myocardial infarction. Circulation, 1996,93:223-228.
  • 7LibbyP, RidkerPM, MaseriA, et al. Inflammation and atherosclerosis. Circulation ,2002,105 : 1135-1143.
  • 8Popma JJ, Califf RM, Topoi E J, et al. Clinical trials of reste-nosis after coronary angioplasty. Circulation, 1991,84 : 1426-1436.
  • 9Aso Y,Fujiwara Y,Tayama K,et al. Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with yon Willebrand factor. Diabetes,2001, 109:210-216.
  • 10Topol E J, Byzova TV, Plow EF, et al. Platelet GPⅡb/Ⅲa blockers. Lancet, 1999,353 : 227 -231.

共引文献185

同被引文献11

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部